In Alzheimer’s disease patients, irritability and anxiety is likely caused by neuroinflammation, which indicates new therapeutic pathways.
List view / Grid view
Alzheimer's disease (AD)
New understanding of “Christchurch mutation” in the APOE gene may lead to novel Alzheimer's disease treatments.
Using RNA sequencing, scientists find that metabolic increase in the brain is an early indicator of Alzheimer's disease.
Discovery about Huntington’s disease may apply to other neurodegenerative disorders, like Alzheimer’s and frontotemporal dementia.
Researchers pinpoint connections of risk variants with microglia functions that are important for Alzheimer’s disease (AD).
For the first time ever, researchers have developed an algorithm to predict age at death and indicate early changes related to disease.
Drugs that boost autophagy hold great promise in preventing and halting neurodegenerative disorders. By ramping up the cell’s waste disposal system, they stimulate the removal of the toxic proteins that are a hallmark of brain conditions such as Alzheimer’s disease and Parkinson’s disease. Now, scientists are harnessing the power of…
New research reveals capillary cells and neurons work together to ensure memory formation and storage.
A growing body of evidence pinpoints neuroinflammation as a pivotal factor driving brain-related pathogenesis. Yet, a crucial question lingers: among the various immune cell groups residing within the brain, which one orchestrates this inflammatory reaction?
US researchers uncover that body building supplement: HMB, may help stop the progression of Alzheimer’s disease.